<qa>  What is the name of the two-by-two factorial design of the patient?Eligible patients will be randomly assigned in a two-by-two factorial design to either medroxyprogesterone MPA, subcutaneous IFN, subcutaneous IL2, or a combination of IFN and IL2. 